Frenette PS, Atweh GF. Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest 2007;117:850–8.10.1172/JCI30920Search in Google Scholar
Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617–21.10.1056/NEJM199006073222301Search in Google Scholar
Elghetany MT, Banki K. Erythrocytic disorders. In: McPherson RA, Pincus MR, eds. Henry’s clinical diagnosis and management by laboratory methods. 21st ed. Philadelphia, PA: Saunders Elsevier, 2007:504–44.Search in Google Scholar
Ogedegbe HO. Sickle cell disease: an overview. Lab Med 2002;33:515–43.10.1309/YKN9-T1N3-DGGM-5KU1Search in Google Scholar
Ohene-Frempong K. Indications for red cell transfusion in sickle cell disease. Semin Hematol 2001;38:5–13.10.1016/S0037-1963(01)90055-1Search in Google Scholar
Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986;314:1593–9.10.1056/NEJM1986061931425013086721Search in Google Scholar
Leikin SL, Gallagher D, Kinney TR, et al. Mortality in children and adolescents with sickle cell disease. Cooperative study of sickle cell disease. Pediatrics 1989;84:500–8.10.1542/peds.84.3.500Search in Google Scholar
Gill FM, Sleeper LA, Weiner SJ, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Blood 1995;86:776–83.10.1182/blood.V86.2.776.bloodjournal862776Search in Google Scholar
Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease-life expectancy and risk factors for early death. N Engl J Med 1994;330:1639–44.10.1056/NEJM1994060933023037993409Search in Google Scholar
Telen MJ. Role of adhesion molecules and vascular endothelium in the pathogenesis of sickle cell disease. Hematol Am Soc Hematol Educ Program 2007;84-90.10.1182/asheducation-2007.1.8418024614Search in Google Scholar
Kupyers FA. Membrane lipid alterations in hemoglobinopathies. Hematology Am Soc Hematol Educ Program 2007;68-73.10.1182/asheducation-2007.1.6818024611Search in Google Scholar
Key NS, Slungaard A, Dandelet L, et al. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood 1998;91:4216–23.10.1182/blood.V91.11.4216Search in Google Scholar
Wang WC. The pathophysiology, prevention, and treatment of stroke in sickle cell disease. Curr Opin Hematol 2007;14:191–7.10.1097/MOH.0b013e3280ec5243Search in Google Scholar
Adams RJ, McKie VC, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992;326:605–10.10.1056/NEJM199202273260905Search in Google Scholar
Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5–11.10.1056/NEJM199807023390102Search in Google Scholar
Adams RJ, McKie VC, Brambilla D, et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials 1998;19:110–29.10.1016/S0197-2456(97)00099-8Search in Google Scholar
Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000;342:1855–65.10.1056/NEJM20000622342250210861320Search in Google Scholar
Sakhalkar VS, Rao SP, Weedon J, Miller ST. Elevated plasma sVCAM-1 levels in children with sickle cell disease: impact of chronic transfusion therapy. Am J Hematol 2004;76:57–60.10.1002/ajh.2001615114598Search in Google Scholar
Styles LA, Abboud M, Larkin S, Lo M, Kuypers FA. Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Br J Haematol 2007;136:343–4.10.1111/j.1365-2141.2006.06409.x17156397Search in Google Scholar
Claster S, Vichinsky EP. Managing sickle cell disease. BMJ 2003;327:1151–5.10.1136/bmj.327.7424.115126181914615343Search in Google Scholar
Platt O, Thorington B, Brambilla D, et al. Pain in sickle cell disease. N Engl J Med 1991;325:11–16.10.1056/NEJM1991070432501031710777Search in Google Scholar
Steinberg MH, Barton F, Castro O, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia. Risks and benefits up to 9 years of treatment. JAMA 2003;289:1645–51.10.1001/jama.289.13.1645Search in Google Scholar
Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317–22.10.1056/NEJM199505183322001Search in Google Scholar
Ware RE, Zimmerman SA, Shultz WH. Hydroxyurea as an alternative to blood transfusion for the prevention of recurrent stroke in children with sickle cell disease. Blood 1999;94:3022–6.10.1182/blood.V94.9.3022Search in Google Scholar
Zimmerman SA, Schultz WH, Burgett S, et al. Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia. Blood 2007;110:1043–7.10.1182/blood-2006-11-057893Search in Google Scholar
Locatelli F, Rocha V, Reed W, et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003;101:2137–43.10.1182/blood-2002-07-2090Search in Google Scholar
Bernaudin F, Socie G, Kuentz M, et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007;110:2749–56.10.1182/blood-2007-03-079665Search in Google Scholar
Woodard P, Jeng M, Handgretinger R, et al. Summary of symposium: the future of stem cell transplantation for sickle cell disease. J Pediatr Hematol Oncol 2002;34:512–17.10.1097/00043426-200210000-00002Search in Google Scholar
Josephson CD, Lu LL, Killyer KL, Hillyer CD. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines. Transfus Med Rev 2007;21:118–33.10.1016/j.tmrv.2006.11.003Search in Google Scholar
Koshy M, Burd L, Wallace D, et al. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. N Engl J Med 1988;319:1447–52.10.1056/NEJM198812013192204Search in Google Scholar
Rackoff WR, Ohene-Frempong K, Month S, et al. Neurologic events after partial exchange transfusion for priapism in sickle cell disease. J Pediatr 1992;120:882–5.10.1016/S0022-3476(05)81954-7Search in Google Scholar
Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. N Engl J Med 1995;333:206–13.10.1056/NEJM1995072733304027791837Search in Google Scholar
Buck J, Casbard A, Llewelyn C, Johnson T, Davies SC, Williamson LM. Preoperative transfusion in sickle cell disease: a survey of practice in England. Eur J Haematol 2005;75:14–21.10.1111/j.1600-0609.2005.00412.x15946305Search in Google Scholar
Platt OS. The acute chest syndrome of sickle cell disease. N Engl J Med 2000;342:1904–7.10.1056/NEJM20000622342251010861328Search in Google Scholar
Adams RJ, Brambilla D; Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005;353:2769–78.10.1056/NEJMoa05046016382063Search in Google Scholar
Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086–92.10.1046/j.1537-2995.2001.41091086.x11552063Search in Google Scholar
Osby M, Shulman IA. Phenotype matching of donor red blood cells units for non alloimmunized sickle cell disease patients: a survey of 1182 North American laboratories. Arch Pathol Lab Med 2005;129:190–3.10.5858/2005-129-190-PMODRB15679419Search in Google Scholar
Afenyi-Annan A, Brecher ME. Pre-transfusion phenotype matching for sickle cell disease patients. Transfusion 2005;44:619–20.10.1111/j.1537-2995.2004.00369.x15043582Search in Google Scholar
Ness PM. To match or not to match: the question for chronically transfused patients with sickle cell anemia. Transfusion 1994;34:558–60.10.1046/j.1537-2995.1994.34794330007.x8053035Search in Google Scholar
Hillyer KL, Hare VW, Josephson CD, et al. Partners for life: the transfused program for patients with sickle cell disease offered at the American Red Cross Blood Services, Southern Region, Atlanta, Georgia. Immunohematology 2006;22:108–11.10.21307/immunohematology-2019-365Search in Google Scholar
Brecher ME. Technical Manual. 15th ed. Bethesda, MD: American Association of Blood Banks, 2005.Search in Google Scholar
King KE, Shirey RS, Lenkiewica MW, et al. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients’ red cells. Transfusion 1997;37:376–81.10.1046/j.1537-2995.1997.37497265337.x9111274Search in Google Scholar
Petz LD, Calhoun L, Shulman IA, et al. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997;37:382–92.10.1046/j.1537-2995.1997.37497265338.x9111275Search in Google Scholar
Win N, Yeghen T, Needs, et al. Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease. Hematology 2004;9:433–6.10.1080/1024533040000192615763986Search in Google Scholar
Porter JB. Concepts and goals in the management oftransfusional iron overload. Am J Hematol 2007;82:1136–9.10.1002/ajh.2110017968973Search in Google Scholar
Blumberg N, Heal JM, Gettings KF. Leukoreduction of red cell transfusion is associated with a decreased incidence of red cell alloimmunization. Transfusion 2003;43:945–52.10.1046/j.1537-2995.2003.00443.x12823755Search in Google Scholar
Mayo Clinic. Sickle cell anemia. Available at: http://www.mayoclinic.com/health/sickle-cell-anemia/DS00324. Accessed July 20, 2009.10.1111/j.1753-4887.1962.tb04643.xSearch in Google Scholar
Sickle Cell Disease Association of America, Inc. Available at: http://www.sicklecelldisease.org/. Accessed July 20, 2009.Search in Google Scholar
March of Dimes. Available at: http://www.marchofdimes.com/. Accessed July 20, 2009.Search in Google Scholar
Lab Tests On Line. Available at: http://www.labtestsonline.org/. Accessed July 20, 2009.Search in Google Scholar
Susan D. Roseff, MD, Medical Director, Transfusion Medicine, Professor, Virginia Commonwealth University, Department of Pathology, PO Box 980662, Richmond VA 23298-0662.Search in Google Scholar
